Sight Sciences (SGHT) Total Non-Current Liabilities (2020 - 2026)
Sight Sciences' (SGHT) quarterly Total Non-Current Liabilities came in at $54.9 million in Q1 2026, up 6.18% year-on-year from $51.7 million in Q1 2025, and up 6.96% quarter-over-quarter from $51.3 million in Q4 2025.
Sight Sciences (SGHT) Total Non-Current Liabilities (2020 - 2026) Analysis & Trends
Sight Sciences' Total Non-Current Liabilities history runs 7 years deep, the most recent figure standing at $54.9 million for Q1 2026.
- On a quarterly basis, Total Non-Current Liabilities rose 6.18% year-over-year to $54.9 million in Q1 2026; TTM through Mar 2026 was $54.9 million, a 6.18% increase from a year earlier, with the FY2025 full-year figure at $51.3 million, down 6.38% from the prior year.
- Total Non-Current Liabilities advanced to $54.9 million in Q1 2026 per SGHT's latest filing, from $51.3 million in the prior quarter.
- Across five years, Total Non-Current Liabilities topped out at $54.9 million in Q1 2026 and bottomed at $44.0 million in Q4 2023.
- The 5-year median for Total Non-Current Liabilities is $50.2 million (2023), against an average of $49.8 million.
- Across the five-year window, Total Non-Current Liabilities fell 16.99% in 2023 and increased 24.71% in 2024, its largest moves.
- Year by year, Total Non-Current Liabilities stood at $53.0 million in 2022, then dropped by 16.99% to $44.0 million in 2023, then gained by 24.71% to $54.8 million in 2024, then decreased by 6.38% to $51.3 million in 2025, then grew by 6.96% to $54.9 million in 2026.
- Per Business Quant, the three latest SGHT Total Non-Current Liabilities figures stand at $54.9 million (Q1 2026), $51.3 million (Q4 2025), and $51.9 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 20.94 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 41.44 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 41.88 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 2.64 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 3.53 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 9.85 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 24.21 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 3.57 Bn |
| 10 | Sight Sciences | 253.53 Mn | 168.57 Mn | 16.98 Mn | 54.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 54.90 Mn |
| Dec 31, 2025 | 51.33 Mn |
| Sep 30, 2025 | 51.95 Mn |
| Jun 30, 2025 | 51.76 Mn |
| Mar 31, 2025 | 51.71 Mn |
| Dec 31, 2024 | 54.82 Mn |
| Sep 30, 2024 | 48.57 Mn |
| Jun 30, 2024 | 47.06 Mn |
| Mar 31, 2024 | 45.39 Mn |
| Dec 31, 2023 | 43.96 Mn |
| Sep 30, 2023 | 48.10 Mn |
| Jun 30, 2023 | 49.12 Mn |
| Mar 31, 2023 | 50.23 Mn |
| Dec 31, 2022 | 52.96 Mn |
| Sep 30, 2022 | 50.54 Mn |
| Jun 30, 2022 | 47.18 Mn |
| Mar 31, 2022 | 46.64 Mn |
| Dec 31, 2021 | 46.16 Mn |
| Sep 30, 2021 | 44.73 Mn |
| Jun 30, 2021 | 44.36 Mn |